Thus, the overwhelming majority of patients with T2DM are insulin resistant, whereas only approximately 50 % of patients with essential hypertension, treated or untreated, are insulin resistant [31], and these differences in prevalence may help explain why it has been so difficult to even establish the existence of a relationship between elevated both pressure and T2DM. This evidence concerns the gene INS and hypertensive disorder.